Compelling data shows cardiovascular beneficial effects in consuming fatty acids highly present in fish, such as omega 3, docosahexanoic acid (DHA 22::6 omega 3), and eicosapentanoic acid (EPA 20::5 omega 3). These fatty acids regulate cell membrane physicochemical properties (i.e., fluidity, organization and permeability) that affect signaling pathways, with probable antioxidant and anti-inflammatory effects on cardiac and vascular tissue. Interest in the physiological and pharmacological effects of omega-3 polyunsaturated fatty acids (PUFA), in particular those of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), has increased significantly in recent years. Omega-3 PUFA, which are recognized as nutraceuticals, have been demonstrated to have clinical benefits for the prevention of and / or treatment of certain pathological conditions. Omega-3 polyunsaturated fatty acids (omega-3 PUFAs) are increasingly being used to prevent cardiovascular disease. Omega-3 PUFAs may prevent atherosclerosis and cardiovascular disease development by targeting arterial stiffness and endothelial dysfunction administration.
Preface; Cardiac Pharmacological Preconditioning Associated with Omega 3 Supplementation:: Potential Clinical Applications; Omega-3 Polyunsaturated Fatty Acids:: A New Option in the Treatment of Pain; Omega-3 Polyunsaturated Fatty Acids in the Treatment of Diabetic Cardiovascular Autonomic Neuropathy:: A Review; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.